PROVIDER PROFILE · NPI 1679972947

Jose BustilloD.O

PRACTICEVERA HOUSee all providers at this practice →

Internal MedicineNewark, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$8K

Peer benchmark

Total Medicare services vs. 3,616 Internal Medicine providers in NJ — bottom quintile (cohort median 895).

PRESCRIBING · PART D · 2024

Total Rx claims

3,603

Beneficiaries

—

Total drug cost

$528K

Distinct drugs

Brand share

24.9%

Top prescribed drugs

Atorvastatin Calcium510 claims

Amlodipine Besylate305 claims

Losartan Potassium172 claims

Empagliflozin153 claims

Hydrochlorothiazide134 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$677

Payment records

By payment type

Food and Beverage$677

REFERRAL NETWORK

Where Jose Bustillo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NEWARK BETH ISRAEL MEDICAL CENTER INC	142	1,013
Doris Koduah Hospitalist · Lakeland, FL	28	82
Anshu Garg Cardiology · Elizabeth, NJ	27	121
UNIVERSITY HOSPITAL	15	34
Michael Sadler Diagnostic Radiology · New York, NY	13	32
John Matthews Diagnostic Radiology · Wilmington, DE	13	46
LEVINSON, ROBERT	12	54
Chunguang Chen Cardiology · Newark, NJ	11	84

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history